Global Statistics Representing Tuberculosis Testing Market Scenario
Tuberculosis is fatal disease caused by bacteria of genus mycobacteria. It mainly targets lungs but bacteria can attack on other body parts as well and cause infection of genitourinary system, lymphatic system and central nervous system. Pulmonary tuberculosis is bacterial infection in lungs while infection in other body parts is extra pulmonary tuberculosis.
For TB detection two main methods are preferred rapid method and routine method. Routine method is prominently and widely preferred including skin test. As per of Centre for disease control and prevention around 9,105 TB cases around (2.8 cases per 100,000 persons) were suffering from TB in 2017. In 2017 only total 1,600,000 deaths were reported due to TB. After this increasing number of the TB patients all over the world the demand of diagnosing kit or testing kits for TB is also increasing.
Global tuberculosis (TB) testing market was valued at around USD 1200 million in 2017 and is expected to grow at a CAGR of 4.1% during the forecast period
The global tuberculosis testing market can be segmented by diagnostic test type and end user.
On the basis of diagnostic test type, the tuberculosis testing market can be segmented into radiographic test, laboratory test, nucleic acid testing, cytokine detection test, drug resistance test, and other diagnostic test types. The laboratory test segment is expected to account for a significant market share during the forecast period.
Based on end user, the market can be segmented into hospital/clinic and diagnostics/research. Among the two, the diagnostics and research segment is expected to lead the market during the forecast period.
Geographically, the global tuberculosis testing market has been segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (LAMEA).
North America is projected to account for the largest share of the global tuberculosis testing market during the forecast period, 2019–2026. The weakening of the immunity system, due to chronic diseases such as HIV is an important cause of tuberculosis. According to the National Aids Control Organisation, in 2015, approximately 1.1 million people suffered from HIV in the U.S. This prevalence of HIV has directly been leading to an increase in the incidences of tuberculosis, which, in turn, drives market growth.
Europe accounts for a significant share of the global tuberculosis testing market, owing to the region’s expanding geriatric population who are prone to chronic diseases. Moreover, the prominent presence of key players in the region further supports market growth.
Asia-Pacific is pegged to be the fastest growing market during the forecast period. In India, government support and early diagnosis of tuberculosis are among the key factors propelling market growth. The Indian government organizes various campaigns to raise awareness regarding tuberculosis, which in turn provides impetus to market growth.
The LAMEA region is expected to witness substantial growth in the global market during the forecast period, owing to the increasing prevalence of tuberculosis and infrastructure improvement in the region.
Some of the key players in the tuberculosis testing market include Abbott Laboratories, Becton Dickinson & Company, BioMerieux SA, Cepheid, F. Hoffmann-La Roche AG, Hain LifeScience GmbH, Hologic Corporation, Qiagen, AdvaCare Pharma, and Thermo Fischer Scientific Inc.
Tuberculosis Testing Market Segmentation
By Diagnostic Test Type
By End User
Why Buy This Report?
This report offers key insights pertaining to the tuberculosis testing market with an emphasis on recent developments across geographies and development strategies adopted by prominent market participants. The following sections have specifically been covered in the report.